Article Text

PDF

Blood lipids and the treatment of essential hypertension with methyldopa and bendrofluazide
  1. L. J. Libman,
  2. T. L. Dormandy,
  3. D. E. Arrowsmith,
  4. Joanna Heal,
  5. B. I. Hoffbrand

    Abstract

    The blood lipids of eight patients with previously untreated essential hypertension have been studied before and after treatment with methyldopa and bendrofluazide. No significant change was found in any of the measurements over a mean treatment period of 5·25 months. These results are believed to provide evidence that hypotensive therapy does not predispose to the development of ischaemic heart disease.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.